Iκκ mediates NF-κB activation in human immunodeficiency virus- infected cells

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 3893-3903

  Asin, Susana ^a   Taylor, Julie A ^a   Trushin, Sergey ^a   Bren, Gary ^a   Paya, Carlos V ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; EPITOPE; FLAG PEPTIDE; HYBRID PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PEPTIDE;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONOCYTE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION; BINDING SITE; CELL STRAIN U937; DRUG ANTAGONISM; GENETICS; METABOLISM; MUTAGENESIS; PHOSPHORYLATION; PHYSIOLOGY;

BINDING SITES; DNA-BINDING PROTEINS; EPITOPES; HIV-1; HUMANS; I-KAPPA B PROTEINS; MUTAGENESIS; NF-KAPPA B; PEPTIDES; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; U937 CELLS; VIRUS REPLICATION;

EID: 0032587951     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.3893-3903.1999     Document Type: Article

References (57)

1. Alcamí, J., T. Laín de Lera, L. Folgueira, M.-A. Pedraza, J.-M. Jacqué, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1995. Absolute dependence on κB responsive elements for initiation and TAT-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
2. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J.-L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature (London) 350:709-712.
3. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB ten years after. Cell 87: 13-20.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
5. Barroga, C. F., J. K. Stevenson, E. M. Schwarz, and I. M. Verma. 1995. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl. Acad. Sci. USA 92:7637-7641.
6. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6: 1899-1913.
7. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism of NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
8. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
9. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
10. Chen, B. K., M. B. Feinberg, and D. Baltimore. 1997. The κB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71: 5495-5504.
11. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteosome pathway. Genes Dev. 9:1586-1587.
12. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862.
13. Cordle, S. R., R. Donald, M. A. Reed, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268: 11803-11810.
14. DeLuca, C., A. Roulston, A. Koromilas, M. A. Wainberg, and J. Hiscott. 1996. Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-κB/Rel pathway via enhanced IκBα degradation. J. Virol. 70:5183-5193.
15. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
16. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
17. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
18. Ferreira, V., N. Tarantino, and M. Körner. 1998. Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IκBα. J. Biol. Chem. 273:592-599.
19. Finzl, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
20. Folgueira, L., J. A. McElhinny, G. D. Bren, W. S. MacMorran, M. T. Diaz-Meco, J. Moscat, and C. V. Paya. 1996. Protein kinase C-ξ mediates NF-κB activation in human immunodeficiency virus-infected monocytes. J. Virol. 70:223-231.
21. Folgueira, L., A. Algeciras, W. S. MacMorran, G. D. Bren, and C. V. Paya. 1996. The ras-raf pathway is activated in human immunodeficiency virus-infected monocytes and participates in the activation of NF-κB. J. Virol. 70: 2332-2338.
22. Fuhlbrigge, R. C., S. M. Fine, E. R. Unanue, and D. D. Chaplin. 1988. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1α cDNA. Proc. Natl. Acad. Sci. USA 85:5649-5653.
23. Fuminori, H., H. Tanaka, Y. Hirano, M. Hiramoto, H. Handa, I. Makino, and C. Scheidereit. 1998. Functional interference of Sp1 and NF-κB through the same DNA binding site. Mol. Cell. Biol. 18:1266-1274.
24. rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J. Biol. Chem. 272:21281-21288.
25. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339:70-73.
26. Haskill, D., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
27. Jacqué, J.-M., B. Fernández, F. Arenzana-Seisdedos, D. Thomas, F. Baleux, J. L. Virelizier, and F. Bachelerie. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-κB is needed for persistent viral replication in monocytes. J. Virol. 70:2930-2938.
28. Kwon, H., N. Pelletier, C. DeLuca, P. Genin, S. Cisternas, R. Lin, M. A. Wainberg, and J. Hiscott. 1998. Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273:7431-7440.
29. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222.
30. Lefkovits, I., and H. Waldmann. 1979. Limiting dilution analysis of cells in the immune system. Cambridge University Press, Cambridge, England.
31. Leonard, J., C. Parrott, A. J. Buckler-White, W. Turner, E. K. Ross, M. A. Martin, and A. B. Rabson. 1989. The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919-4924.
32. Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of relB in lymphoid cells. EMBO J. 13:4060-4069.
33. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401-1409.
34. McElhinny, J. A., W. S. MacMorran, G. D. Bren, R. M. Ten, A. Israel, and C. V. Paya. 1995. Regulation of IκBα and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69:1500-1509.
35. McElhinny, J. A., S. A. Trushin, G. D. Bren, N. Chester, and C. V. Paya. 1996. Casein kinase II phosphorylates IκBα at S-283, S-288, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:899-906.
36. Meltzer, M. S., D. R. Skillman, D. L. Hoover, B. D. Hanson, J. A. Turpin, D. Chester Kalter, and H. E. Gendelman. 1990. Macrophages and the human immunodeficiency virus. Immunol. Today 11:217-223.
37. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Wu Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. Iκκ-1 and Iκκ-2: cytokine-activated IκB kinases essential for NFκB activation. Science 278:860-866.
38. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
39. Oh, S. H. I., and R. B. Gaynor. 1995. Intracellular factors involved in gene expression of human retroviruses, p. 97-187. In J. A. Levy (ed.). The Retroviridae, 4th ed. Plenum Press, New York, N.Y.
40. Paya, C. V., R. M. Ten, C. Bessia, J. Alcami, and R. T. Hay. 1992. NF-κB-dependent induction of the NF-κB p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc. Natl. Acad. Sci. USA 89:7826-7830.
41. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effect in vivo. J. Biol. Chem. 272:21096-21103.
42. Régnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
43. Roulston, A., M. D'Addario, F. Boulerice, S. Caplan, M. A. Wainberg, and J. Hiscott. 1992. Induction of monocyte differentiation and NF-κB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J. Exp. Med. 175:751-752.
44. Schouten, G. J., A. C. O. Vertegaal, S. T. Whiteside, A. Israel, M. Toebes, J. C. Dorsman, A. J. van der Eb, and A. Zantema. 1997. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:3133-3144.
45. Schwarz, E. M., D. V. Antwerp, and I. M. Verma. 1996. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα. Mol. Cell. Biol. 16:3554-3559.
46. Sun, S.-C., J. Elwood, and W. C. Greene. 1996. Both amino- and carboxylterminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16:1058-1065.
47. Sun, S.-C., J. Elwood, C. Beraud, and W. C. Greene. 1994. Human T-cell leukemia type 1 tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα- and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377-7384.
48. Suzan, M., D. Salaun, C. Neuveut, B. Spire, I. Hirsch, P. de Bouteiller, G. Querat, and J. Sire. Induction of NF-κB during monocyte differentiation by HIV type 1 infection. J. Immunol. 146:377-383.
49. Traenckner, E. B.-M., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NFκB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
50. Van Antwerp, D. J., and I. M. Verma. 1996. Signal-induced degradation of IκBα: association with NF-κB and the PEST sequence in IκBα are not required. Mol. Cell. Biol. 16:6037-6045.
51. Wang, L., S. Mukherjee, F. Jia, O. Narayan, and L.-J. Zhao. 1995. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and transactivation of viral long terminal repeat. J. Biol. Chem. 270:25564-25569.
52. Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N- and C-terminal sequences control degradation of MAD3/ IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15:5339-5345.
53. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-β: NFκB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
54. Wu, B.-Y., C. Wofendin, C. S. Duckett, T. Ohno, and G. J. Nabel. 1995. Regulation of human retroviral latency by the NF-κB/IκBα family: inhibition of human immunodeficiency virus replication by IκB through a Rev-dependent mechanism. Proc. Natl. Acad. Sci. USA 92:1480-1484.
55. Wu, B.-Y., C. Wofendin, I. MacLachlan, and G. J. Nabel. 1997. Distinct domains of IκBα inhibit human immunodeficiency virus type 1 replication through NF-κB and Rev. J. Virol. 71:3161-3167.
56. Yin, M.-J., L. B. Christerson, Y. Yamamoto, Y.-T. Kwak, S. Xu, F. Mercurio, M. Barbosa, M. H. Cobb, and R. B. Gaynor. 1998. HTLV-1 Tax protein binds to Mekk1 to stimulate IκB kinase activity and NF-κB activation. Cell 93: 875-884.
57. Zandi, E., D. M. Torhwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (Iκκ) contains two kinase subunits, Iκκα and Iκκβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243-252.